Clinical Trial Update: A Study of Bimatoprost 0.01% in the Clinical Setting

View source ↗

Summary

The document reports the completion of a clinical trial evaluating bimatoprost 0.01% for primary open-angle glaucoma and ocular hypertension. Results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2015-10-26